• Houston-based Kiromic BioPharma finds buyer for assets after filing Chapter 7 The Business Journals Mon, 07 Apr 2025 07:00:00 GMT
• financial contrast: kiromic biopharma (nasdaq:krbp) and finch therapeutics group (nasdaq:fnch) Defense World Fri, 28 Mar 2025 07:00:00 GMT
• financial contrast: sab biotherapeutics (nasdaq:sabs) versus kiromic biopharma (nasdaq:krbp) Defense World Sun, 23 Mar 2025 07:00:00 GMT
• kiromic biopharma files for chapter 7 bankruptcy by investing.com Investing.com Australia Fri, 21 Mar 2025 22:18:52 GMT
• Houston cancer treatment co. files for bankruptcy months after settling SEC charges The Business Journals Fri, 21 Mar 2025 07:00:00 GMT
• kiromic furloughs ‘substantially all’ workers amid cash crunch, leaving 31 staff without pay Fierce Biotech Tue, 18 Mar 2025 09:42:03 GMT
• Kiromic furloughs 'substantially all' workers amid cash crunch, leaving 31 staff without pay Fierce Biotech Tue, 18 Mar 2025 07:00:00 GMT
• Empress Therapeutics confirms layoffs; Nanobiotix amends J&J deal terms Endpoints News Tue, 18 Mar 2025 07:00:00 GMT
• kiromic biopharma (nasdaq:krbp) stock price down 7.1% – time to sell? Defense World Tue, 25 Feb 2025 08:00:00 GMT
• kiromic says deltacel-01 trial patient reaches progression-free survival TipRanks Thu, 20 Feb 2025 09:54:27 GMT
• kiromic biopharma reports patient 4 in deltacel-01 clinical trial reaches 10-month progression-free survival Lelezard Tue, 18 Feb 2025 13:20:25 GMT
• breakthrough in nsclc treatment: patient achieves 10-month cancer-free milestone with novel cell therapy StockTitan Tue, 18 Feb 2025 08:00:00 GMT
• kiromic says deltacel-01 trial patient reaches progression-free survival TipRanks Tue, 18 Feb 2025 08:00:00 GMT
• kiromic biopharma issues 25% senior secured convertible promissory note Defense World Wed, 05 Feb 2025 07:31:48 GMT
• Kiromic BioPharma Reports Tumor Volume Decrease in Two Patients Enrolled in Deltacel-01 Business Wire Tue, 21 Jan 2025 08:00:00 GMT
• kiromic files to raise $17m through uplisting (krbp:otcqb) Seeking Alpha Tue, 21 Jan 2025 08:00:00 GMT
• kiromic biopharma: favorable efficacy reported in deltacel-01 phase1 trial TipRanks Tue, 21 Jan 2025 08:00:00 GMT
• kiromic biopharma (nasdaq:krbp) stock price down 2.7% – here’s why Defense World Fri, 03 Jan 2025 08:00:00 GMT
• kiromic biopharma (nasdaq: krbp) issues senior secured convertible promissory note to accredited investor Defense World Sat, 14 Dec 2024 15:27:14 GMT
• kiromic's cancer drug shows 32% tumor reduction in phase 1 trial: key clinical data released StockTitan Thu, 12 Dec 2024 13:00:00 GMT
• Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01 Business Wire Thu, 12 Dec 2024 08:00:00 GMT
• kiromic biopharma issues $2 million convertible note by investing.com Investing.com UK Wed, 11 Dec 2024 21:56:00 GMT
• texas con man pockets $12m pretending to protect victims from fake mexican cartel threats Inkl Sun, 08 Dec 2024 15:10:45 GMT
• financial crime weekly: ceo sentenced to 51 months in prison, kiromic biopharma charged with failure to disclose material informat... Benzinga Sat, 07 Dec 2024 08:00:00 GMT
• kiromic biopharma c-suite execs charged with misleading investors Financial Regulation News Fri, 06 Dec 2024 01:06:48 GMT
• irs issues warning about bad tax advice on social media Financial Regulation News Thu, 05 Dec 2024 21:56:48 GMT
• tacoma-based sound credit union acquires washington business bank Financial Regulation News Thu, 05 Dec 2024 21:52:40 GMT
• kiromic biopharma c-suite execs charged with misleading investors Financial Regulation News Thu, 05 Dec 2024 08:00:00 GMT
• u.k., eu enforcement regimes set to escalate, but critics question sanctions' effectiveness Compliance Week Wed, 04 Dec 2024 16:35:29 GMT
• drugmaker ex-ceo hit with sec suit over cancer drug filings (1) Bloomberg Law News Wed, 04 Dec 2024 08:00:00 GMT
• sec charges biopharma with misleading investors about status of inds Cooley PubCo Wed, 04 Dec 2024 08:00:00 GMT
• biotech startup avoids sec penalties through voluntary self-report Legal Dive Wed, 04 Dec 2024 08:00:00 GMT
• Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation Business Wire Tue, 03 Dec 2024 08:00:00 GMT
• sec settles charges with kiromic biopharma for misleading investors, issues penalties for former execs The Business Journals Tue, 03 Dec 2024 08:00:00 GMT
• sec levies no fine against kiromic biopharma after material omissions self-disclosure Compliance Week Tue, 03 Dec 2024 08:00:00 GMT
• sec charges kiromic bio with misleading investors about status of fda reviews TipRanks Tue, 03 Dec 2024 08:00:00 GMT
• kiromic biopharma resolves sec investigation with no penalties over fda clinical hold disclosure StockTitan Tue, 03 Dec 2024 08:00:00 GMT
• therapeutics co. expands houston footprint | tech project consultant comes to texas The Business Journals Mon, 02 Dec 2024 17:39:45 GMT
• kiromic biopharma (fra:5ju0) momentum rank : 9 (as of nov. 28, 2024) GuruFocus.com Fri, 29 Nov 2024 00:40:43 GMT
• kiromic biopharma (fra:5ju0) 3-year eps without nri growth rate : 56.40% (as of sep. 2024) GuruFocus.com Fri, 29 Nov 2024 00:33:36 GMT
• kiromic biopharma (nasdaq:krbp) stock price down 3.5% – time to sell? Defense World Sat, 23 Nov 2024 07:09:11 GMT
• mereo biopharma group plc (mph.l) (lon:mph) trading down 1.9% – here’s what happened Defense World Sat, 23 Nov 2024 07:09:05 GMT
• webcast: the doj’s corporate whistleblower program: what we’ve learned and how it can change in the future Compliance Week Thu, 21 Nov 2024 08:00:00 GMT
• novel t-cell immunotherapies market share, size, growth and forecast to 2031 InsightAce Analytic Fri, 08 Nov 2024 08:00:00 GMT
• lung cancer awareness month 2024: looking back at progress for cell and gene therapy CGTLive™ Thu, 07 Nov 2024 08:00:00 GMT
• new trump era could be a boon for biopharma m&a, dealmaking Endpoints News Wed, 06 Nov 2024 08:00:00 GMT
• krbp (kiromic biopharma) price-to-operating-cash-flow : (as of nov. 02, 2024) GuruFocus.com Sat, 02 Nov 2024 05:41:20 GMT
• cpe webcast: protect your business: mastering whistleblower reporting for smbs Compliance Week Tue, 29 Oct 2024 07:00:00 GMT
• sec charges virginia-based rtx corp. with violating foreign corrupt practices act in connection with efforts to obtain contracts w... Newsfile Wed, 16 Oct 2024 07:00:00 GMT
• around the helix: cell and gene therapy company updates – october 16, 2024 CGTLive™ Wed, 16 Oct 2024 07:00:00 GMT
• krbp (kiromic biopharma) dividends per share : $0.00 (ttm as of jun. 2024) GuruFocus.com Mon, 14 Oct 2024 16:57:47 GMT
• teva pharma to pay $450m to settle kickback, price-fixing allegations Compliance Week Fri, 11 Oct 2024 07:00:00 GMT
• Kiromic BioPharma’s NSCLC T-cell Therapy Deltacel Continues to Provide Disease Stabilization in Updated Data CGTLive® Thu, 10 Oct 2024 07:00:00 GMT
• kiromic biopharma reports favorable ongoing clinical results from fourth and sixth patients enrolled in deltacel-01 StockTitan Tue, 08 Oct 2024 12:00:00 GMT
• kiromic biopharma, inc. reports favorable ongoing clinical results from fourth and sixth patients enrolled in deltacel-01 Marketscreener.com Tue, 08 Oct 2024 12:00:00 GMT
• anixa biosciences seeks protocol change to enable repeat dosing in trial for ovarian cancer cer-t CGTLive™ Wed, 02 Oct 2024 07:00:00 GMT
• allogeneic t-cell therapy produces efficacy at 10 months in stage iv metastatic nsclc OncLive Tue, 01 Oct 2024 07:00:00 GMT
• kiromic biopharma gives follow-up results for 1st patient in deltacel trial TipRanks Tue, 01 Oct 2024 07:00:00 GMT
• kiromic biopharma reports favorable 10-month follow-up results for the first patient treated in its deltacel-01 clinical trial StockTitan Tue, 01 Oct 2024 07:00:00 GMT
• kiromic biopharma issues series e preferred stock in debt exchange Investing.com Mon, 30 Sep 2024 07:00:00 GMT
• fincen, ofac sanction crypto platforms linked to russia, cybercrime Compliance Week Fri, 27 Sep 2024 07:00:00 GMT
• around the helix: cell and gene therapy company updates – september 25, 2024 CGTLive™ Wed, 25 Sep 2024 07:00:00 GMT
• kiromic biopharma gets greenlight to move to dose expansion in trial for nsclc t-cell therapy deltacel CGTLive™ Tue, 24 Sep 2024 07:00:00 GMT
• krbp - kiromic biopharma inc latest stock news & market updates StockTitan Fri, 20 Sep 2024 18:30:00 GMT
• kiromic biopharma advances deltacel-01 into expansion phase following safety monitoring committee's unanimous recommendation Investing.com Thu, 19 Sep 2024 07:00:00 GMT
• kiromic biopharma activates the university of arizona cancer center as the fifth clinical trial site in the ongoing phase 1 deltac... StockTitan Thu, 19 Sep 2024 07:00:00 GMT
• analyzing ikena oncology (nasdaq:ikna) & kiromic biopharma (nasdaq:krbp) Defense World Wed, 18 Sep 2024 06:19:59 GMT
• data roundup: august 2024 features updates in car-t, mrna therapy, and gamma delta t-cell therapy for various cancers CGTLive™ Tue, 17 Sep 2024 07:00:00 GMT
• vironexis biotherapeutics’ aav vector-based immunotherapy vnx-101 cleared for us trial in acute lymphoblastic leukemia CGTLive™ Tue, 17 Sep 2024 07:00:00 GMT
• sec charges former chairman and ceo of tech co. kubient with fraud and lying to auditors Newsfile Mon, 16 Sep 2024 07:00:00 GMT
• cartesian therapeutics doses first patient with mrna car-t descartes-15 in trial for r/r multiple myeloma CGTLive™ Fri, 06 Sep 2024 07:00:00 GMT
• fda activity recap: august 2024 features tcr t-cell therapy approval, rems modification, the lifting of a clinical hold, and more CGTLive™ Wed, 04 Sep 2024 07:00:00 GMT
• orgenesis’ car-t org-101 demonstrates efficacy and safety in acute lymphoblastic leukemia in real-world study in china CGTLive™ Fri, 30 Aug 2024 07:00:00 GMT
• legend biotech’s car-t carvykti approved for r/r mm indication in china CGTLive™ Wed, 28 Aug 2024 07:00:00 GMT
• jw therapeutics’ relma-cell approved in china for r/r mantle cell lymphoma CGTLive™ Tue, 27 Aug 2024 07:00:00 GMT
• fda grants fast track designation to deltacel plus radiation for pretreated metastatic nsclc www.oncnursingnews.com/ Sat, 24 Aug 2024 07:00:00 GMT
• critical analysis: kiromic biopharma (nasdaq:krbp) & voyager therapeutics (nasdaq:vygr) Defense World Sat, 24 Aug 2024 05:23:43 GMT
• bms’s application for expanded liso-cel indication in follicular lymphoma validated by ema CGTLive™ Wed, 21 Aug 2024 07:00:00 GMT
• kiromic biopharma inc- the gf score's 5 key aspects of analysis GuruFocus.com Mon, 19 Aug 2024 13:15:13 GMT
• kiromic puts gamma delta t-cells to the test for lung cancer in deltacel-01 clinical trial CGTLive™ Mon, 19 Aug 2024 07:00:00 GMT
• fda grants priority review to durvalumab for ls-sclc after concurrent chemoradiotherapy OncLive Thu, 15 Aug 2024 14:06:23 GMT
• fda grants fast track status to kiromic's lung cancer therapy Investing.com Thu, 15 Aug 2024 10:56:42 GMT
• fda grants fast track designation for kb-gdt-01 to treat patients with non-small cell lung cancer Pharmacy Times Thu, 15 Aug 2024 07:00:00 GMT
• kiromic biopharma cfo buys $3,500 in company stock by investing.com Investing.com UK Wed, 14 Aug 2024 21:06:00 GMT
• dr raez on the fda approval of repotrectinib in ntrk+ solid tumors OncLive Wed, 14 Aug 2024 16:30:00 GMT
• deltacel plus radiation wins fda fast track designation for pretreated metastatic nsclc OncLive Wed, 14 Aug 2024 07:00:00 GMT
• sec charges russell todd burkhalter and his atlanta-based firm with $300 million ponzi scheme and obtains emergency relief Newsfile Wed, 14 Aug 2024 07:00:00 GMT
• kiromic biopharma’s deltacel receives fda fast track designation | krbp stock news StockTitan Wed, 14 Aug 2024 07:00:00 GMT
• fda grants fast track status to kiromic's lung cancer therapy Investing.com Wed, 14 Aug 2024 07:00:00 GMT
• kiromic biopharma’s nsclc t-cell therapy deltacel generates favorable pfs data in interim phase 1 trial results CGTLive™ Tue, 13 Aug 2024 07:00:00 GMT
• krbp stock earnings: kiromic biopharma reported results for q2 2024 MSN Mon, 12 Aug 2024 15:10:30 GMT
• kiromic reports update from phase i nsclc treatment trial Yahoo Finance Mon, 12 Aug 2024 07:00:00 GMT
• novel t-cell therapy may show pfs benefit in stage iv metastatic nsclc Cancer Network Mon, 12 Aug 2024 07:00:00 GMT
• kiromic biopharma reports interim results of nsclc treatment phase i trial World Pharmaceutical Frontiers Mon, 12 Aug 2024 07:00:00 GMT
• t-cell therapy deltacel elicits early safety and efficacy in nsclc OncLive Fri, 09 Aug 2024 07:00:00 GMT
• kiromic biopharma reports interim results from deltacel-01 trial TipRanks Fri, 09 Aug 2024 07:00:00 GMT
• kiromic biopharma provides update on part 1 of the deltacel-01 trial StockTitan Fri, 09 Aug 2024 07:00:00 GMT
• ngk insulators (otcmkts:ngkif) trading down 7.3% American Banking and Market News Tue, 06 Aug 2024 08:21:57 GMT
• estrella immunopharma’s trial for cd19-targeted t-cell therapy eb103 in b-cell lymphomas doses first patient CGTLive™ Tue, 06 Aug 2024 07:00:00 GMT
• contrasting lexeo therapeutics (nasdaq:lxeo) & kiromic biopharma (nasdaq:krbp) Defense World Fri, 02 Aug 2024 11:03:24 GMT
• umoja biopharma's in situ car-t therapy cleared for us trial in hematologic malignancies CGTLive™ Thu, 01 Aug 2024 07:00:00 GMT
• michael severino on in vivo gene editing with rna gene writers CGTLive™ Thu, 01 Aug 2024 07:00:00 GMT
• kiromic biopharma reports 20% tumor size reduction at eight months in first patient enrolled in deltacel-01 StockTitan Thu, 01 Aug 2024 07:00:00 GMT
• around the helix: cell and gene therapy company updates – july 31, 2024 CGTLive™ Wed, 31 Jul 2024 07:00:00 GMT
• jacques galipeau, md, on exponential progress with cell and gene therapy CGTLive™ Thu, 25 Jul 2024 07:00:00 GMT
• gene switch / molecular switch market latest report 2024-2031 InsightAce Analytic Mon, 22 Jul 2024 07:00:00 GMT
• kiromic biopharma (stu:5ju0) median ps value : €0.00 (as of oct. 16, 2024) GuruFocus.com Sat, 20 Jul 2024 04:20:28 GMT
• kiromic biopharma to advance deltacel-01 clinical trial to part 2, expansion phase Winchester Herald Chronicle Thu, 18 Jul 2024 07:00:00 GMT
• around the helix: cell and gene therapy company updates – july 17, 2024 CGTLive™ Wed, 17 Jul 2024 07:00:00 GMT
• second-generation nk cell engager heading to trial for cd33+ leukemia CGTLive™ Fri, 12 Jul 2024 07:00:00 GMT
• paul y. song, md, on bringing snk01 to clinical trials for parkinson disease CGTLive™ Fri, 12 Jul 2024 07:00:00 GMT
• lisa nieland on slowing tumor growth in glioblastoma with novel aav therapy CGTLive™ Thu, 11 Jul 2024 07:00:00 GMT
• kiromic biopharma secures $2m in convertible note financing by investing.com Investing.com Canada Thu, 11 Jul 2024 00:03:50 GMT
• textron delivers first skycourier with combi interior by investing.com Investing.com Wed, 10 Jul 2024 18:54:26 GMT
• kiromic biopharma secures $2m in convertible note financing Investing.com India Wed, 10 Jul 2024 07:00:00 GMT
• paul y. song, md, on using autologous natural killer cells to treat parkinson disease CGTLive™ Wed, 10 Jul 2024 07:00:00 GMT
• around the helix: cell and gene therapy company updates – july 10, 2024 CGTLive™ Wed, 10 Jul 2024 07:00:00 GMT
• paul y. song, md, on taking a holistic approach to treating parkinson disease CGTLive™ Mon, 08 Jul 2024 07:00:00 GMT
• car-t pipeline analysis 2024: clinical trials, fda, ema, and pmda approvals, emerging therapies, and growth EIN News Mon, 01 Jul 2024 12:14:00 GMT
• kiromic biopharma converts debt to preferred stock, issues new note by investing.com Investing.com Australia Fri, 28 Jun 2024 06:02:19 GMT
• ra capital management buys $49.95m of eliem therapeutics stock by investing.com Investing.com Thu, 27 Jun 2024 23:12:53 GMT
• kiromic biopharma's strategic financial restructuring and equity shift - tipranks.com TipRanks Thu, 27 Jun 2024 21:59:22 GMT
• fda issues crl for patritumab deruxtecan in pretreated egfr+ nsclc OncLive Thu, 27 Jun 2024 07:00:00 GMT
• kiromic biopharma converts debt to preferred stock, issues new note Investing.com Thu, 27 Jun 2024 07:00:00 GMT
• around the helix: cell and gene therapy company updates – june 26, 2024 CGTLive™ Wed, 26 Jun 2024 07:00:00 GMT
• kiromic biopharma provides updates on its deltacel-01 clinical trial Winchester Herald Chronicle Thu, 20 Jun 2024 12:00:30 GMT
Kiromic BioPharma, Inc(NASDAQ:KRBP) 
Kiromic BioPharma, Inc., a target discovery and gene editing company, focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. Its product portfolio include ALEXIS AIDT-1, an allogenic CAR cell product candidate targeting AIDT-1; ALEXIS AIDT-2 EOC, an a...
Website: http://www.kiromic.com
Founded: 2006
Full Time Employees: 11
CEO: Maurizio Chiriva-Internati
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends